EIT Health and MIRACUM collaborate to organize Real World Data Workshop in Erlangen

Symbolic picture for the article. The link opens the image in a large view.
Foto: EIT Health Germany

On 22 February 2018, EIT Health Germany co-organized the International EIT Health Workshop on “Real World Data in Healthcare” together with ETH Zürich, FAU, Roche Diagnostics GmbH and Siemens Healthineers, in collaboration with MIRACUM, both hosted in Erlangen. The event attracted more than 80 international participants (from Germany, France, Spain, Belgium, the UK, Switzerland and the Netherlands) to discuss needs and challenges in real world evidence for new health products and services. The participants of the Real World Data in Healthcare Workshop and the MIRACUM Symposium had the opportunity to share ideas and exchange information with a combined number of participants of nearly 300 during the breaks. Partners from EIT Health Germany, who joined the event, included for example AbbVie, Bayer, Bio-M, DKFZ, ETH Zürich, FAU, Roche Diagnostics GmbH, SAP, Siemens Healthineers and TUM.

Prof. Dr. Jochen Klucken from the Division of Molecular Neurology moderated the event in an inspiring way that demonstrated his passion for improving the patient experience and outcomes.  Prof. Dr. Hans-Ulrich Prokosch, Chair of Medical Informatics, together with Prof. Dr. Dr. h.c. Jürgen Schüttler, Dean of the Faculty of Medicine, opened the event by highlighting how informatics and technology can help to leverage the value of real world data in healthcare.

We need to enhance cross-country healthcare collaboration and data mobility to support future innovative healthcare solutions.

emphasized Dr. Katharina Ladewig, Managing Director of EIT Health Germany and EIT Health UK-Ireland, in her welcoming speech.

A highlight of the day was the impressive keynote speech by Dr. Melvin Olson, Global Head of Real World Evidence & Innovation of Novartis on “Leveraging Real World Data to Improve Outcomes in Healthcare”. By showing strengths and weaknesses of data collection and data analysis, he explained the role of a pharma company and the importance of shifting the business model for outcomes-based healthcare. Other topics mentioned during the day included, for example, data ownership, data privacy and security, patient engagement and artificial intelligence.

In the World Café participants discussed at round-tables how to overcome the challenges and later presented the highlights from the group discussion. The interactive format allowed participants to share their views on topics like sharing medical data, value from data in clinical and sub-clinical settings, Digital Eco-system, legal framework for processing data in the healthcare environment or fusing data science and simulation for understanding healthcare provision.

The event was an excellent way to kick-off EIT Health projects that foster activities in data-driven innovation and create value from data in clinical and subclinical settings. Interested EIT Health partners can still submit Innovation Project proposals by 9 April 2018. For individuals not linked to an EIT Health partner, there is the opportunity to apply to the wildcard initiative.

About EIT Health

EIT Health is one of the largest healthcare initiatives worldwide. Its goal is to sustainably advance the fundamentals of healthcare and thus promote suitable future conditions for healthy living, active ageing and improved well-being of people across Europe. EIT Health leverages the expertise of more than 140 member organizations from the pharma, diagnostics and med tech fields, payers, insurances, research institutions and universities.

More information about EIT Health
More information about EIT Health Germany

Further information

Christine Neumann, Communication & Public Affairs Manager, EIT Health Germany
Phone: +49 (0) 621 76446114
Additional information on the workshop